KATHRYN PETRIE: Open Payments
NPI 1619365632 · FITZGERALD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 25 payments from 11 companies in 2025. Trend: 2023 $705 · 2024 $701 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $116 |
| Novo Nordisk Inc | 4 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| ABBVIE INC. | 2 | $33 |
| Ardelyx, Inc. | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 3 | $28 |
| PFIZER INC. | 1 | $25 |
| Eisai Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
Products named: TRELEGY ELLIPTA, Ozempic, AIRSUPRA, FANAPT, VRAYLAR, IBSRELA, VOQUEZNA, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
